Eisaku Nakamura
Direttore/Membro del Consiglio presso KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD.
Profilo
Eisaku Nakamura is currently an Independent Outside Director at D.
Western Therapeutics Institute, Inc. and Kubota Pharmaceutical Holdings Co. Ltd.
He is also an Auditor at KOINOBORI Associate, Inc. In the past, he worked as a Director at Acucela, Inc.
Posizioni attive di Eisaku Nakamura
| Società | Posizione | Inizio |
|---|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Direttore/Membro del Consiglio | 01/03/2016 |
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Direttore/Membro del Consiglio | 29/03/2018 |
| KOINOBORI Associate, Inc. | Comptroller/Controller/Auditor | 01/01/2017 |
Precedenti posizioni note di Eisaku Nakamura
| Società | Posizione | Fine |
|---|---|---|
| ACUCELA INC | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Health Technology |
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
| KOINOBORI Associate, Inc. |
- Borsa valori
- Insiders
- Eisaku Nakamura
